News Digging > News > Exercise in a pill? That’s the focus of Cambrian’s new pipeline company
Exercise in a pill? That’s the focus of Cambrian’s new pipeline company
Exercise in a pill? That's the focus of Cambrian's new pipeline company,In line with its anti-aging central theme, Cambrian BioPharma has a new clinical candidate to work with, going after what CEO James Peyer described as a “Holy Grail target.” The New York drug developer announced the launch of its newest pipeline company, Amplifier Therapeutics, Tuesday morning. Cambrian is investing $26

Exercise in a pill? That’s the focus of Cambrian’s new pipeline company

In line with its anti-aging central theme, Cambrian BioPharma has a new clinical candidate to work with, going after what CEO James Peyer described as a “Holy Grail target.” The New York drug developer announced the launch of its newest pipeline company, Amplifier Therapeutics, Tuesday morning. Cambrian is investing $26